SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shalby informs about disclosure

08 Dec 2021 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated 9th September, 2015, Shalby has informed that the Company's Wholly-owned Subsidiary Mars Medical Devices (MMDL) has further subscribed 2,09,000 equity shares of SGD 1 each in MMDL'S Subsidiary Shalby Global Technologies, Singapore (SGTPL), and remitted funds for the same on December 7, 2021. SGTPL is a subsidiary of Mars Medical Devices and a Step-down Subsidiary of the Company. Shareholding of MMDL in SGTPL is now increased from 96% to 97.82%.

The above information is a part of company’s filings submitted to BSE.


Shalby Share Price

168.70 1.25 (0.75%)
08-May-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×